Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Burn and Scald Medicine Market Report. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Burn and Scald Medicine Market Trends and Forecast

The future of the global burn and scald medicine market looks promising with opportunities in the hospital & clinic, retail pharmacy, and e-commerce platform markets. The global burn and scald medicine market is expected to grow with a CAGR of 4.8% from 2025 to 2031. The major drivers for this market are the increasing prevalence of burn injuries, the rising awareness of burn care treatments, and the growing demand for advanced wound healing solutions.

• Lucintel forecasts that, within the type category, ointment is expected to witness the highest growth over the forecast period due to the increasing preference for effective treatment solutions.
• Within the application category, e-commerce platform is expected to witness the highest growth due to the rising adoption of online healthcare product shopping.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Burn and Scald Medicine Market Trends and Forecast

Burn and Scald Medicine Market by Segment

Emerging Trends in the Burn and Scald Medicine Market

The burn and scald medicine market is witnessing a major transformation, fueled by emerging trends like the creation of new technologies, increasing use of personalized medicine, and increased awareness of burn treatment. These trends are transforming the way burns are treated, managed, and rehabilitated, impacting both the patients and healthcare providers. With advancements in wound healing devices and an expanding emphasis on reducing scars and controlling pain, the trends are directing the market toward more efficient and affordable treatments.
• Personalized Burn Care: Personalized burn care is increasingly gaining popularity, where treatments are customized to patients according to their individual condition, genetic profile, and severity of burns. Genomics advancements and personalized medicine allow physicians to anticipate improved results for patients and choose the most ideal treatments. With the customized way of approaching care, burn therapies are getting better, lowering healing time, and decreasing complications later on. The trend helps patients get the best therapy in which they would suit best, promoting quicker recovery.
• Advanced Wound Healing Technologies: Advanced wound healing technologies are transforming the Burn and Scald Medicine market. New dressings for wounds, including hydrocolloids, hydrogels, and collagen-based dressings, are greatly enhancing burn care. These technologies facilitate quicker healing by keeping the wound moist, avoiding infection, and minimizing the need for repeated dressing changes. Biologics and skin substitutes are also proving to be game-changers in wound healing, giving patients improved outcomes in terms of reduced scarring and recovery time.
• Scar Management Solutions: Scar management is now an essential part of burn care, with resulting demand for products that reduce the formation of scars. New treatments, such as silicone gels, pressure garments, and laser treatments, are being used to enhance aesthetic and functional results for burn survivors. Scar management solutions are especially crucial for those who have experienced severe burns, as they not only facilitate physical healing but also play a role in the psychological health of the patient. This trend is driving the market towards more integrated, post-treatment care solutions.
• Expanded Utilization of Artificial Skin and Biologics: The use and development of artificial skin and biologics in the treatment of burns are expanding significantly. These products are used to substitute damaged skin, speeding up wound healing and minimizing infection. Artificial skin substitutes are offering patients a graft alternative with fewer complications and improved functional results. The application of biologics, such as stem cell therapy, is also increasing as it aids in the regrowth of tissue and enhanced healing, enhancing burn survivor quality of life and decreasing healthcare expenses.
• Telemedicine and Remote Monitoring: Telemedicine and remote monitoring are new trends in burn care, particularly where there is limited access to specialist burn centers. Remote consultations, computerized wound evaluation, and follow-up treatment are enabling healthcare professionals to track burn patients remotely, providing improved access to care while minimizing the requirement for repeated visits to the hospital. This movement is especially advantageous for rural or underserved area patients, allowing them to receive the required treatment without having to make long trips. Telemedicine is enhancing patient outcomes by making interventions timely.
These new trends are transforming the burn and scald medicine market by providing improved treatment, expanding access to care, and improving patient outcomes. Personalized medicine, cutting-edge technologies, and innovation in biologics and artificial skin are dramatically enhancing the management of burn injuries, while telemedicine is improving access to burn care. As such trends keep developing, they will continue to fuel more growth in the market, providing new avenues for patients and healthcare providers alike.
Emerging Trends in the Burn and Scald Medicine Market

Recent Development in the Burn and Scald Medicine Market

Burn and scald medicine market has witnessed a range of recent developments aimed at enhancing the outcome of treatment, lessening recovery time, and minimizing the risk of complications. These improvements have been brought about due to constant research, innovative technologies, and increasing emphasis on customized care. Some of the major developments include the launch of new products related to wound care, biologics, and innovative treatments that are revolutionizing the treatment scenario.
• Introduction of Stem Cell Therapies and Biologics: Stem cell therapies and biologics have become revolutionary treatments in the field of burns. Stem cell-based treatments are being utilized to improve healing and regenerate tissue in burn patients at a faster rate. These treatments are minimizing the necessity for skin grafts and providing patients with improved functional and cosmetic results. By promoting tissue regeneration and boosting the bodyÄX%$%Xs own healing mechanism, biologics and stem cells are helping to revolutionize the way in which recovery times are reduced and scarring is minimized.
• Skin Substitutes: Skin substitutes have been engineered as a replacement for conventional skin grafts, with improved healing and outcomes. Such substitutes are produced using biological substances or artificial polymers, which copy the characteristics of human skin, offering a viable option for burn patients. Substitutes are less invasive, with a lower risk of rejection. Skin substitutes are integral in severe burn care, offering a consistent option for wound closure and minimizing the risk of complications.
• Progress in Wound Care Products: Developments in wound care products, including complex dressings and bioactive bandages, are revolutionizing the treatment of burns. These products help heal faster, decrease the risk of infection, and cause less pain. Hydrocolloid dressings, hydrogel-containing products, and antimicrobial treatments are some of the newest advancements in wound care. These products create a healing environment by maintaining moisture in the wound, shielding it against external pathogens, and stimulating tissue growth.
• Analgesic and Pain Management Innovations: Creating new pain management treatments for burn victims is an important improvement in the field of burn medicine. New analgesics and regional anesthesia strategies are under investigation to better manage pain with reduced side effects. Pain management innovations are vital to enhancing the patientÄX%$%Xs overall experience because burns are severely painful. These advances are assisting in reducing the usage of opioids, thereby reducing the chances of addiction and other adverse effects while providing assurance that the patients feel successful pain relief during healing.
• Greater Emphasis on Scar Reducing Technologies: Scar reduction is now a focal area of burn treatment, with the development of new technologies and therapies to reduce scarring. Methods like laser treatment, silicone sheeting, and pressure garments are being employed to prevent and minimize scarring, enhancing the cosmetic and functional recovery for burn survivors. These developments are assisting in mitigating the psychological impact of scarring since patients can heal with fewer cosmetic complications in the long term.
The major advancements within the burn and scald medicine market are greatly enhancing the treatment environment for patients with burns. Biologics, substitutes of skin, top-of-the-line wound care products, pain management technologies, and scar reduction devices are fueling innovation in burn treatment, providing greater results and less recovery time. These advancements are driving the market, making burn care more effective, more accessible, and less invasive.

Strategic Growth Opportunities in the Burn and Scald Medicine Market

The burn and scald medicine market offers various growth opportunities in major applications. The growth areas are developments in wound care, pain management, scar reduction, and the creation of more cost-effective treatments. Established and emerging players are seeking innovative solutions to meet the increasing demand for burn care treatments. The market is growing, fueled by a growing demand for specialized burn care across different geographies and a growing emphasis on enhancing patient outcomes.
• Wound Care Solution Expansion: The growth of wound care solutions is a huge growth opportunity, fueled by advances in materials science and biotechnology. Hydrocolloid dressings, bioactive bandages, and skin substitutes are gaining popularity based on their healing time and complication reduction. Wound care is still an important aspect of burn therapy with greater demand for recovery-enhancing and infection-preventing products. Growth in this category is imperative to satisfy increased hospital and home care demand for higher-level wound care products.
• Expansion in Scar Management Solutions: Scar management solutions are a new growth field in the field of burn medicine, with increased attention on enhancing cosmetic and functional results for burn survivors. Innovative treatments such as silicone-based gels, pressure garments, and laser treatments are increasing their popularity due to their capacity to mitigate scarring. This growth segment is fueled by the growing awareness of the psychological effect of burn scars and the need for effective scar management technologies. Firms are investing in creating new scar reduction solutions to address the requirements of burn survivors.
• Telemedicine and Remote Care Emergence: The emergence of telemedicine and remote care for burn patients is a one-of-a-kind opportunity for growth. With remote monitoring systems and digital health technologies, burn care professionals are able to provide consultations, monitor healing, and intervene early if needed. This opportunity for growth is particularly precious in areas with limited access to specialized burn facilities, enabling increased access to care and lower healthcare costs. Telemedicine allows more patients to be treated with timely, expert care, and this is a valuable opportunity for market growth.
• Greater Emphasis on Stem Cell Therapies and Biologics: Utilization of biologics and stem cell therapies for treatment of burns is an emerging focus area. The novel treatments work to speed tissue repair and regeneration. Stem cell therapies and biologic products are less invasive substitutes for conventional grafting methods with the potential for enhancing cosmetic as well as functional results. This development opportunity is drawing high levels of investment from pharmaceutical firms, and thus it is an area of development and commercialization for burn care.
• Pain Management Solution Advances: Pain management is still an integral part of burn care, an ever-growing market opportunity. Advances in new analgesic drugs, as well as non-pharmacologic approaches such as regional anesthesia, are enhancing burn patientsÄX%$%X ability to cope with pain. Pain management advances enhance patient satisfaction and recovery rates, and the growing emphasis on minimizing opioid use creates another growth opportunity within this market.
Strategic opportunities for growth in the burn and scald medicine market are fueling innovation and enhancing patient outcomes. Wound care therapies, scar treatment, telemedicine, biologics, and pain management are some of the growth areas that are transforming the landscape of burn care. These opportunities are anticipated to increase access to cutting-edge treatments, lower recovery times, and improve the overall patient experience. The market is on track to grow as these opportunities materialize.

Burn and Scald Medicine Market Driver and Challenges

The burn and scald medicine market is driven by several drivers and challenges emanating from technology, economics, and regulation. Technological improvement in wound healing, as well as growing knowledge of burn prevention and treatment methods, are significant drivers of growth in the market. Despite this, market development can be hindered by challenges like regulatory barriers, high expenditure on expensive treatments, and poor access to healthcare in some areas. These elements will need to be addressed if the market continues to develop.
The factors responsible for driving the burn and scald medicine market include:
1. Advances in Treatment Technology: Advances in technology in the treatment of burns, such as the creation of sophisticated wound care products, skin substitutes, and biologics, are key drivers of market growth. These innovations facilitate faster healing, minimize scarring, and enhance patient outcomes. Advances such as artificial skin and stem cell therapies are revolutionizing burn care by making treatment more efficient and less intrusive. These innovations are changing the market by providing new, superior alternatives for burn victims, increasing demand for more advanced solutions.
2. Increasing Awareness of Burn Treatment Solutions: As the awareness of burn prevention and treatment grows, an increasing number of individuals are looking for advanced burn care solutions. Public campaigns and educational programs are reducing the incidence of burns and encouraging better awareness of available treatments. As more people approach medical treatment for burns, the demand for advanced treatments is on the rise, which is fueling the market. Healthcare professionals are continually providing specialized services to cater to this need, thus driving market growth.
3. Growth in Burn Incidents: Increased incidents of burns due to industrial accidents, domestic fires, and other factors are driving the demand for burn care services and products. With growing populations and urbanization, the occurrence of burns is expected to increase, leading to increased demand for the market. Consequently, greater resources are being invested in burn prevention initiatives, while healthcare systems are making investments in enhancing burn care infrastructure, accelerating market growth.
4. Aging Population: The aging population, especially in developed nations such as Japan and Germany, is a key growth driver for the burn and scald medicine market. Older people are more vulnerable to burns, partly because of decreased sensory response and comorbidities. With the aging population rising worldwide, the need for specialized burn care is likely to increase. This demographic trend is driving innovation in the creation of age-related treatments and solutions for burn care.
5. Government and Regulatory Support: Governments worldwide are increasingly acknowledging the significance of burn care and putting policies in place to enhance access to treatment. Healthcare subsidies and regulatory incentives, available in some nations, are financing new treatments and therapies for burn care. Government programs like research funding and burn prevention campaigns are also driving growth in the market by promoting innovation and enhancing public health outcomes.
Challenges in the burn and scald medicine market are:
1. Excessive Cost of Advanced Treatments: One of the most important challenges confronting the burn and scald medicine market is the excessive cost of advanced treatments, including biologics and stem cell therapies. These treatments, while highly effective, are often excessively costly for many patients, especially in developing nations or for those lacking insurance coverage. The expensive nature of burn care may restrict availability to the optimum treatments and market growth potential in some areas.
2. Regulatory Hurdles: The development and approval of new burn treatment products are subject to strict regulatory standards, which can delay product launches and increase the cost of bringing new treatments to market. Regulatory hurdles vary from country to country, making it challenging for companies to navigate the approval process. These barriers can slow down innovation and limit the availability of new burn care solutions, hindering market growth.
3. Restricted Access to Specialized Burn Care: In certain areas, especially in low- and middle-income countries, there is restricted access to specialized burn care owing to poor healthcare infrastructure and the lack of skilled healthcare workers. Such restricted access to burn care services can lead to delayed treatment, more complications, and worse outcomes for burn patients. These differences in access to care need to be addressed if the growth and expansion of the market for burn and scald medicine is to continue.
The challenges and drivers of the burn and scald medicine market reflect the multifaceted nature of this industry. Technological advancements, increasing awareness, and an aging population are driving growth, but high costs of advanced treatments, regulatory barriers, and restricted access to care pose challenges. Conquering these challenges while leveraging emerging opportunities will be essential for the ongoing success of the market.

List of Burn and Scald Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies burn and scald medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the burn and scald medicine companies profiled in this report include-
• Mebao Pharmaceutical Technology Group
• B. Braun
• Integra LifeSciences
• Jinyao Darentang
• Smith & Nephew
• Yangtze River Pharmaceutical Group
• STADA Thornton & Ross
• Kenvue Brands
• Changchun Overseas Pharmaceutical Group
• Orkla Health

Burn and Scald Medicine Market by Segment

The study includes a forecast for the global burn and scald medicine market by type, application, and region.

Burn and Scald Medicine Market by Type [Value from 2019 to 2031]:


• Ointment
• Spray
• Oil
• Others

Burn and Scald Medicine Market by Application [Value from 2019 to 2031]:


• Hospitals & Clinics
• Retail Pharmacies
• E-Commerce Platforms
• Others

Burn and Scald Medicine Market by Region [Value from 2019 to 2031]:


• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Burn and Scald Medicine Market

The recent trends in the burn and scald medicine market of major regions like the United States, China, Germany, India, and Japan are influenced by various forces such as technological innovation, rising healthcare awareness, and changing treatment patterns. These countries have witnessed an upsurge in research, innovation, and new product introductions for the better management and treatment of scald and burn injuries. Governments, healthcare institutions, and pharmaceutical firms are collaborating to enhance patient outcomes through improved pain management, wound healing, and infection prevention. This has resulted in tremendous market growth and greater access to sophisticated treatments for burn and scald patients.
• United States: In the United States, the burn and scald medicine market has witnessed growth as a result of the development of advanced wound care products and enhanced treatment protocols. Firms are prioritizing the provision of new solutions like biologics and skin substitutes to enhance wound healing. Further, the increase in industrial accidents and domestic burn cases has triggered increased demand for burn care products. The United States also realizes a high degree of investment and research in the treatment of burns and is thereby a front-runner in the creation of new and advanced therapies.
• China: ChinaÄX%$%Xs market for burn and scald medicine has been growing with rising industrial development, urbanization, and a changing healthcare system. With a huge population, burn injuries are a major issue, and the government has invested in improved healthcare infrastructure and the creation of treatment. The application of traditional Chinese medicine (TCM) in combination with modern burn treatments has also gained popularity. Local pharmaceutical firms are concentrating on developing affordable yet effective remedies for the increasing rates of burn injuries in the nation.
• Germany: Germany is a leader in Europe regarding burn care innovation. With a robust healthcare system and continuous research into new solutions, Germany has witnessed the introduction of numerous new treatments for burns. The availability of advanced-tech dressings, stem cell treatments, and artificial skin is assisting in the improvement of patient results. Moreover, GermanyÄX%$%Xs research focus and cooperation with biotech companies is instrumental in burn and scald medicineÄX%$%Xs ongoing development. Excessive healthcare expenditure and robust regulatory systems have propelled this marketÄX%$%Xs growth.
• India: IndiaÄX%$%Xs burn and scald medicine market is developing very fast in response to growing burn injury rates, both accidents and socio-economic causes like domestic violence. IndiaÄX%$%Xs healthcare system continues to advance, with rising demand for new burn care products. Local players and multinational corporations are targeting cost-effective wound care products, particularly for rural segments. With growing awareness about the treatment of burns, specialist burn centers are needed more and more. Medical tourism for the care of burns is becoming more common in India because of affordable treatments.
• Japan: Technological development leads the burn and scald medicine market in Japan, with the availability of artificial skin and novel biologics to heal wounds more effectively. JapanÄX%$%Xs aging population has resulted in an increased number of elderly people with burn injuries, especially within families. Consequently, the need for sophisticated burn therapies is increasing. Japanese enterprises are pioneering the establishment of highly sophisticated burn care solutions. JapanÄX%$%Xs healthcare system provides effective treatment to burn patients, driving market growth and innovation in the field of burn medicine.
Lucintel Analytics Dashboard

Features of the Global Burn and Scald Medicine Market

Market Size Estimates: Burn and scald medicine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Burn and scald medicine market size by type, application, and region in terms of value ($B).
Regional Analysis: Burn and scald medicine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the burn and scald medicine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the burn and scald medicine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

Lucintel Consulting Services

FAQ

Q1. What is the growth forecast for burn and scald medicine market?
Answer: The global burn and scald medicine market is expected to grow with a CAGR of 4.8% from 2025 to 2031.
Q2. What are the major drivers influencing the growth of the burn and scald medicine market?
Answer: The major drivers for this market are the increasing prevalence of burn injuries, the rising awareness of burn care treatments, and the growing demand for advanced wound healing solutions.
Q3. What are the major segments for burn and scald medicine market?
Answer: The future of the burn and scald medicine market looks promising with opportunities in the hospital & clinic, retail pharmacy, and e-commerce platform markets.
Q4. Who are the key burn and scald medicine market companies?
Answer: Some of the key burn and scald medicine companies are as follows:
• Mebao Pharmaceutical Technology Group
• B. Braun
• Integra LifeSciences
• Jinyao Darentang
• Smith & Nephew
• Yangtze River Pharmaceutical Group
• STADA Thornton & Ross
• Kenvue Brands
• Changchun Overseas Pharmaceutical Group
• Orkla Health
Q5. Which burn and scald medicine market segment will be the largest in future?
Answer: Lucintel forecasts that, within the type category, ointment is expected to witness the highest growth over the forecast period due to the increasing preference for effective treatment solutions.
Q6. In burn and scald medicine market, which region is expected to be the largest in next 5 years?
Answer: In terms of region, APAC is expected to witness the highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the burn and scald medicine market by type (ointment, spray, oil, and others), application (hospitals & clinics, retail pharmacies, e-commerce platforms, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

For any questions related to Burn and Scald Medicine Market, Burn and Scald Medicine Market Size, Burn and Scald Medicine Market Growth, Burn and Scald Medicine Market Analysis, Burn and Scald Medicine Market Report, Burn and Scald Medicine Market Share, Burn and Scald Medicine Market Trends, Burn and Scald Medicine Market Forecast, Burn and Scald Medicine Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
                                                            Table of Contents

            1. Executive Summary

            2. Global Burn and Scald Medicine Market : Market Dynamics
                        2.1: Introduction, Background, and Classifications
                        2.2: Supply Chain
                        2.3: Industry Drivers and Challenges

            3. Market Trends and Forecast Analysis from 2019 to 2031
                        3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
                        3.2. Global Burn and Scald Medicine Market Trends (2019-2024) and Forecast (2025-2031)
                        3.3: Global Burn and Scald Medicine Market by Type
                                    3.3.1: Ointment
                                    3.3.2: Spray
                                    3.3.3: Oil
                                    3.3.4: Others
                        3.4: Global Burn and Scald Medicine Market by Application
                                    3.4.1: Hospitals & Clinics
                                    3.4.2: Retail Pharmacies
                                    3.4.3: E-commerce Platforms
                                    3.4.4: Others

            4. Market Trends and Forecast Analysis by Region from 2019 to 2031
                        4.1: Global Burn and Scald Medicine Market by Region
                        4.2: North American Burn and Scald Medicine Market
                                    4.2.1: North American Market by Type: Ointment, Spray, Oil, and Others
                                    4.2.2: North American Market by Application: Hospitals & Clinics, Retail Pharmacies, E-commerce Platforms, and Others
                        4.3: European Burn and Scald Medicine Market
                                    4.3.1: European Market by Type: Ointment, Spray, Oil, and Others
                                    4.3.2: European Market by Application: Hospitals & Clinics, Retail Pharmacies, E-commerce Platforms, and Others
                        4.4: APAC Burn and Scald Medicine Market
                                    4.4.1: APAC Market by Type: Ointment, Spray, Oil, and Others
                                    4.4.2: APAC Market by Application: Hospitals & Clinics, Retail Pharmacies, E-commerce Platforms, and Others
                        4.5: ROW Burn and Scald Medicine Market
                                    4.5.1: ROW Market by Type: Ointment, Spray, Oil, and Others
                                    4.5.2: ROW Market by Application: Hospitals & Clinics, Retail Pharmacies, E-commerce Platforms, and Others

            5. Competitor Analysis
                        5.1: Product Portfolio Analysis
                        5.2: Operational Integration
                        5.3: Porter’s Five Forces Analysis

            6. Growth Opportunities and Strategic Analysis
                        6.1: Growth Opportunity Analysis
                                    6.1.1: Growth Opportunities for the Global Burn and Scald Medicine Market by Type
                                    6.1.2: Growth Opportunities for the Global Burn and Scald Medicine Market by Application
                                    6.1.3: Growth Opportunities for the Global Burn and Scald Medicine Market by Region
                        6.2: Emerging Trends in the Global Burn and Scald Medicine Market
                        6.3: Strategic Analysis
                                    6.3.1: New Product Development
                                    6.3.2: Capacity Expansion of the Global Burn and Scald Medicine Market
                                    6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Burn and Scald Medicine Market
                                    6.3.4: Certification and Licensing

            7. Company Profiles of Leading Players
                        7.1: Mebao Pharmaceutical Technology Group
                        7.2: B. Braun
                        7.3: Integra LifeSciences
                        7.4: Jinyao Darentang
                        7.5: Smith & Nephew
                        7.6: Yangtze River Pharmaceutical Group
                        7.7: STADA Thornton & Ross
                        7.8: Kenvue Brands
                        7.9: Changchun Overseas Pharmaceutical Group
                        7.10: Orkla Health
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Burn and Scald Medicine Market Report: Trends, Forecast and Competitive Analysis to 2031 Full Report $ 4,850
A 150 Page Report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process. 
 

Please sign in below to get report brochure - Burn and Scald Medicine Market Report.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )

Follow us on